Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier ® as a Treatment for Life-Threatening Viruses

SAN DIEGO, Sept. 12, 2017 -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has received an Expedited Access Pathway (EAP) designation from the United States Food and Drug Administration (FDA) to support the advancement of the Aethlon Hemopurifier® to treat life-threatening viruses. The FDA EAP program was established to facilitate more rapid patient access to breakthrough technologies with the potential to address life threatening disease conditions for which no approved or cleared treatment alternatives exist.

Category: Biotech

Published: 12 September 2017

Written by Editor

Aldeyra Therapeutics Announces Positive Results from Dry Eye Disease Phase 2a Clinical Trial

Statistically and Clinically Significant Improvement Across Multiple Sign and Symptom Endpoints

Onset of Action Observed Within One Week of Therapy

Phase 2b Clinical Trial Expected to be Initiated in the First Half of 2018

LEXINGTON, Mass., Sept. 12, 2017 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to endogenous aldehyde toxicity, today announced positive results from a Phase 2a clinical trial of topical ocular ADX-102 in patients with dry eye disease.

Category: Biotech

Published: 12 September 2017

Written by Editor

Nasdaq Up on News Project Update

Callinex Intersects 18.7 Meters of 5.8% Zn Eq. at the Nash Creek Zinc Project

Highlights: Drill hole NC17-245 intersected 18.7m of 5.8% Zn Eq. including a higher grade interval of 5.0m grading 8.9% Zn Eq.; and

NC17-245 was completed to test the theory that historic drilling intersected unreported mineralization due to inadequate sampling based on visual observations.

VANCOUVER, Sept. 12, 2017 - Callinex Mines Inc. (the "Company" or "Callinex") (TSX-V: CNX; OTCQX: CLLXF) is pleased to announce results from four drill holes completed at the Company's 100% owned Nash Creek Project located within the Bathurst Mining District of New Brunswick (See Figures 1 and 2). Hole NC17-245 was drilled approximately 20m from historic drill hole NC79-06 that had only one 1.3m sample taken which assayed 2.2% Zn and 0.4% Pb (See Figure 3). The drill hole was completed to test the theory that historic drilling may have intersected unidentified mineralization due to inadequate sampling based on visual observations (See Figure 4). Drill hole NC17-245 was collared into mineralization and the first 19 samples all intersected above 2.5% zinc equivalent mineralization ("Zn Eq.") resulting in an 18.7m intersection grading 5.8% Zn Eq. (4.6% Zn, 0.7% Pb and 23.1 g/t Ag) beginning at 10m depth including a higher grade interval of 5.0m of 8.9% Zn Eq. (7.2% Zn, 1.2% Pb and 31.4 g/t Ag) (See Table 1).

Category: Base Metals

Published: 12 September 2017

Written by Editor

Drill Results Up on News TSXV

Read more: Callinex Mines Inc ( CNX )

VANCOUVER – September 12, 2017 - LottoGopher Holdings Inc. ("LottoGopher" or the "Company") (OTCQB: LTTGF) (CSE: LOTO) (Frankfurt: 2LG) is excited to announce that actor, director, author and singer, William Shatner, has partnered up with LottoGopher to become the spokesperson for the Company. Shatner is a pop icon and Canadian-born actor best recognized for his roles on Star Trek, Boston Legal and T.J. Hooker. He was born in Montreal in 1931 and began his career as a child performer in radio programs for the Canadian Broadcasting Corporation (CBC).

Click this link to view Shatner’s video announcement: William Shatner Announces LottoGopher Collaboration.

Read this news in full at http://www.investorideas.com/news/2017/gaming/09121LottoGopher.asp

Category: Submitted Articles

Published: 12 September 2017

Written by Investor Ideas

Accenture (NYSE: ACN) and Certus Solutions have been selected by the United Kingdom Home Office to deliver a new enterprise resource planning (ERP) system designed to transform the way the Home Office delivers back-office services across finance, procurement, human resources (HR), customer service and payroll-related functions. The two-year contract, valued at approximately £20 million, was awarded after a competitive tendering process and under the U.K. government’s G-Cloud (G8) supplier framework.

The goal of the project is to help the Home Office reduce operational costs, increase operational efficiencies and improve service levels through adoption of new technology applications and processes across its HR, finance, procurement, payroll and customer service functions.

Category: Submitted Articles

Published: 12 September 2017

Written by RealWire